Pulmonx (LUNG) Accumulated Expenses (2019 - 2025)

Pulmonx (LUNG) has 7 years of Accumulated Expenses data on file, last reported at $14.6 million in Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $14.6 million, down 11.63% year-over-year; the trailing twelve-month figure through Dec 2025 was $14.6 million (down 11.63% YoY), and the FY2025 annual result was $14.6 million, down 11.63% from the prior year.
• Accumulated Expenses retreated to $14.6 million in Q4 2025 per LUNG's latest filing, from $14.9 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $16.5 million in Q4 2024 and troughed at $9.8 million in Q1 2021.
• A 5-year average of $12.7 million and a median of $12.6 million in 2021 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2021 and 2022: Accumulated Expenses surged 54.5% in 2021, then slipped 13.17% in 2022.
• A 5-year view of Accumulated Expenses shows it stood at $13.4 million in 2021, then retreated by 0.67% to $13.3 million in 2022, then increased by 22.28% to $16.2 million in 2023, then climbed by 1.47% to $16.5 million in 2024, then decreased by 11.63% to $14.6 million in 2025.
• Business Quant data shows LUNG's Accumulated Expenses at $14.6 million in Q4 2025, $14.9 million in Q3 2025, and $14.4 million in Q2 2025.